(3R)-4-(4-bromophenyl)-1-[(3R)-3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-3-methylbutan-1-one;N,N'-dimethylethane-1,2-diamine;3-(2-hydroxyethyl)-1H-benzimidazol-2-one;1-(2-hydroxyethyl)-3-[4-[(2R)-4-[(3R)-3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-2-methyl-4-oxobutyl]phenyl]benzimidazol-2-one;methane
C80H115BrN12O8 — CID 159211475
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3R)-4-(4-bromophenyl)-1-[(3R)-3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-3-methylbutan-1-one;N,N'-dimethylethane-1,2-diamine;3-(2-hydroxyethyl)-1H-benzimidazol-2-one;1-(2-hydroxyethyl)-3-[4-[(2R)-4-[(3R)-3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-2-methyl-4-oxobutyl]phenyl]benzimidazol-2-one;methane
(3R)-4-(4-bromophenyl)-1-[(3R)-3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-3-methylbutan-1-one;N,N'-dimethylethane-1,2-diamine;3-(2-hydroxyethyl)-1H-benzimidazol-2-one;1-(2-hydroxyethyl)-3-[4-[(2R)-4-[(3R)-3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-2-methyl-4-oxobutyl]phenyl]benzimidazol-2-one;methane (PubChem CID 159211475) has the molecular formula C80H115BrN12O8 and a molecular weight of 1452.78 g/mol. Its IUPAC name is (3R)-4-(4-bromophenyl)-1-[(3R)-3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-3-methylbutan-1-one;N,N'-dimethylethane-1,2-diamine;3-(2-hydroxyethyl)-1H-benzimidazol-2-one;1-(2-hydroxyethyl)-3-[4-[(2R)-4-[(3R)-3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-2-methyl-4-oxobutyl]phenyl]benzimidazol-2-one;methane.
Molecular Properties
| Compound Name | (3R)-4-(4-bromophenyl)-1-[(3R)-3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-3-methylbutan-1-one;N,N'-dimethylethane-1,2-diamine;3-(2-hydroxyethyl)-1H-benzimidazol-2-one;1-(2-hydroxyethyl)-3-[4-[(2R)-4-[(3R)-3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-2-methyl-4-oxobutyl]phenyl]benzimidazol-2-one;methane |
|---|---|
| PubChem CID | 159211475 |
| Molecular Formula | C80H115BrN12O8 |
| Molecular Weight | 1452.78 g/mol |
| Exact Mass | 1450.81 |
| IUPAC Name | (3R)-4-(4-bromophenyl)-1-[(3R)-3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-3-methylbutan-1-one;N,N'-dimethylethane-1,2-diamine;3-(2-hydroxyethyl)-1H-benzimidazol-2-one;1-(2-hydroxyethyl)-3-[4-[(2R)-4-[(3R)-3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-2-methyl-4-oxobutyl]phenyl]benzimidazol-2-one;methane |
| SMILES | C.C.C.C.CNCCNC.COCCCn1c([C@@H]2CCCN(C(=O)C[C@H](C)Cc3ccc(-n4c(=O)n(CCO)c5ccccc54)cc3)C2)nc2ccccc21.COCCCn1c([C@@H]2CCCN(C(=O)C[C@H](C)Cc3ccc(Br)cc3)C2)nc2ccccc21.O=c1[nH]c2ccccc2n1CCO |
| InChI | InChI=1S/C36H43N5O4.C27H34BrN3O2.C9H10N2O2.C4H12N2.4CH4/c1-26(23-27-14-16-29(17-15-27)41-33-13-6-5-12-32(33)40(20-21-42)36(41)44)24-34(43)38-18-7-9-28(25-38)35-37-30-10-3-4-11-31(30)39(35)19-8-22-45-2;1-20(17-21-10-12-23(28)13-11-21)18-26(32)30-14-5-7-22(19-30)27-29-24-8-3-4-9-25(24)31(27)15-6-16-33-2;12-6-5-11-8-4-2-1-3-7(8)10-9(11)13;1-5-3-4-6-2;;;;/h3-6,10-17,26,28,42H,7-9,18-25H2,1-2H3;3-4,8-13,20,22H,5-7,14-19H2,1-2H3;1-4,12H,5-6H2,(H,10,13);5-6H,3-4H2,1-2H3;4*1H4/t26-,28-;20-,22-;;;;;;/m11....../s1 |
| InChIKey | KQNUULPEIWRSJQ-GSSYGACWSA-N |
| XLogP | 13.25 |
| TPSA | 223.96 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 17 |
| Rotatable Bonds | 26 |
| Heavy Atoms | 101 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1452.78 |
| LogP ≤ 5 | 13.25 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 17 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159211475 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.